Intellimedix Overview

  • Founded
  • 2012
  • Status
  • Private
  • Employees
  • 9
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $2.3M
Latest Deal Amount
  • Investors
  • 3

Intellimedix General Information


Developer of novel technologies and approaches to accelerate the discovery of new treatments for neurological diseases. The company analyzes mutations in human genes to identify the diseases a person might have a propensity to develop and suggest compounds (both existing and new) that may be effective in treating the disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Primary Office
  • 171 17th. Street
  • Suite 1525
  • Atlanta, GA 30363
  • United States
+1 (770) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Intellimedix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 23-Feb-2015 $2.3M 00.00 Completed Startup
To view Intellimedix’s complete valuation and funding history, request access »

Intellimedix Executive Team (5)

Name Title Board Seat Contact Info
Jim Richards President & Chief Executive Officer
Jim Jacoby Chairman & Founder
Jeffrey Skolnick Ph.D Chief Scientific Officer
You’re viewing 3 of 5 executive team members. Get the full list »

Intellimedix Board Members (1)

Name Representing Role Since
Jim Jacoby Intellimedix Chairman & Founder 000 0000
To view Intellimedix’s complete board members history, request access »

Intellimedix Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Intellimedix Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Chris Klaus Angel (individual) Minority 000 0000 000000 0
Jim Jacoby Angel (individual) Minority 000 0000 000000 0
NeuroLaunch Accelerator/Incubator Minority 000 0000 000000 0
To view Intellimedix’s complete investors history, request access »